Author Archives: Alice Melão

Ra Pharma and Camurus Agree to Develop Extended-release Formulation of Zilucoplan

Camurus AB and Ra Pharmaceuticals have signed an agreement to develop and manufacture a long-acting injectable formulation of zilucoplan for patients with complement-mediated disorders, such as generalized myasthenia gravis. Using Camurus’s proprietary FluidCrystal technology, the subcutaneously injected formulation will allow patients with complement-mediated disorders — such as…

Other Diseases and Treatment Reactions Common in Myasthenia Gravis Patients, Study in India Finds

Almost 90% of patients diagnosed with myasthenia gravis develop other diseases, or comorbidities, while about 70% have treatment-related complications, a review study from India reports. These additional disorders may contribute to a poorer outcome for these people, making early recognition and management of comorbidities essential for improving patient care and overall…

Presence of Anti-LRP4 Antibodies in Blood May Be Common to Myasthenia Gravis and ALS, Case Study Suggests

Myasthenia gravis and amyotrophic lateral sclerosis (ALS) may share common underlying cellular mechanisms mediated by anti-LRP4 antibodies, a rare case report into both diseases being diagnosed in an elderly patient suggests. The study, “Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine…

Adipokines Could Help Assess Course of Myasthenia Gravis, Study Suggests

Hormones produced by adipose (fat) tissue, called adipokines, can help assess the progression and status of myasthenia gravis, researchers suggest. A team at Medical University of Silesia in Poland assessed the association between the levels of different adipokines and clinical factors that characterize myasthenia gravis. The study, “…